BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1299 related articles for article (PubMed ID: 12709465)

  • 81. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Antihypertensive drug therapies and the risk of ischemic stroke.
    Klungel OH; Heckbert SR; Longstreth WT; Furberg CD; Kaplan RC; Smith NL; Lemaitre RN; Leufkens HG; de Boer A; Psaty BM
    Arch Intern Med; 2001 Jan; 161(1):37-43. PubMed ID: 11146696
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
    Lindholm LH; Ibsen H; Dahlöf B; Devereux RB; Beevers G; de Faire U; Fyhrquist F; Julius S; Kjeldsen SE; Kristiansson K; Lederballe-Pedersen O; Nieminen MS; Omvik P; Oparil S; Wedel H; Aurup P; Edelman J; Snapinn S;
    Lancet; 2002 Mar; 359(9311):1004-10. PubMed ID: 11937179
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
    Gupta A; Mackay J; Whitehouse A; Godec T; Collier T; Pocock S; Poulter N; Sever P
    Lancet; 2018 Sep; 392(10153):1127-1137. PubMed ID: 30158072
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
    de Leeuw PW; Notter T; Zilles P
    J Hypertens; 1997 Jan; 15(1):87-91. PubMed ID: 9050975
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Current treatment of patients with hypertension: therapeutic implications of INSIGHT.
    Taddei S; Ghiadoni L; Salvetti A
    Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
    BMJ; 1992 Feb; 304(6824):405-12. PubMed ID: 1445513
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients.
    Elliott WJ; Hewkin AC; Kupfer S; Cooper-DeHoff R; Pepine CJ
    J Clin Hypertens (Greenwich); 2005 Nov; 7(11):654-63. PubMed ID: 16278523
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
    Franse LV; Pahor M; Di Bari M; Shorr RI; Wan JY; Somes GW; Applegate WB
    J Hypertens; 2000 Aug; 18(8):1149-54. PubMed ID: 10954008
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
    JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Mbewu A; Opie LH
    Cochrane Database Syst Rev; 2012 Nov; 11():CD002003. PubMed ID: 23152211
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Controversies surrounding the treatment of the hypertensive patient with diabetes.
    Prisant LM; Louard RJ
    Curr Hypertens Rep; 1999 Dec; 1(6):512-20. PubMed ID: 10981115
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
    Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The treatment of severe hypertension with trandolapril, verapamil, and hydrochlorothiazide. Trandolapril/Verapamil Multicenter Study Group.
    Punzi HA; Novrit BA
    J Hum Hypertens; 1997 Aug; 11(8):477-81. PubMed ID: 9322827
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
    Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA
    J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
    Schroeder EB; Chonchol M; Shetterly SM; Powers JD; Adams JL; Schmittdiel JA; Nichols GA; O'Connor PJ; Steiner JF
    Clin J Am Soc Nephrol; 2018 May; 13(5):727-734. PubMed ID: 29572286
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.
    Niskanen L; Hedner T; Hansson L; Lanke J; Niklason A;
    Diabetes Care; 2001 Dec; 24(12):2091-6. PubMed ID: 11723089
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Calcium channel blockers versus other classes of drugs for hypertension.
    Chen N; Zhou M; Yang M; Guo J; Zhu C; Yang J; Wang Y; Yang X; He L
    Cochrane Database Syst Rev; 2010 Aug; (8):CD003654. PubMed ID: 20687074
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effect of hypotensive drugs on the circadian blood pressure pattern in essential hypertension: a comparative study.
    Zakopoulos N; Stamatelopoulos S; Moulopoulos S
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):795-9. PubMed ID: 9512875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.